SC
TWST icon

Stempoint Capital’s Twist Bioscience TWST Stock Holding History

Stempoint Capital’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-43,110
Closed -$2.05M – 112
2026
Q1 		$2.05M Sell
43,110
-475,245
-92% -$21.3M 0.39% 52
2025
Q4 		$16.4M Buy
+518,355
New +$16.2M 2.82% 9

Other funds holding TWST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Stempoint Capital's TWST Position: Q2 2026 in Review

Stempoint Capital sold out of Twist Bioscience (TWST) in Q2 2026, closing a stake of 43,110 shares — an estimated $2.05M sold.

Stempoint Capital first reported a position in TWST in Q4 2025 and held it in 2 quarters. The position peaked at $16.4M in Q4 2025. 336 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Stempoint Capital reported no remaining Twist Bioscience position as of Q2 2026 after selling out during the quarter.
  • Stempoint Capital sold 43,110 Twist Bioscience shares in Q2 2026, an estimated $2.05M.
  • Stempoint Capital first reported a position in Twist Bioscience in Q4 2025 and held it in 2 quarters.
  • Stempoint Capital's Twist Bioscience position peaked at $16.4M in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Stempoint Capital's 13F filing for Q2 2026, filed 14 Aug 2026.